Literature DB >> 8362342

Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions.

A W Ford-Hutchinson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8362342     DOI: 10.1007/bf00204625

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  62 in total

1.  Inhibition of human leukocyte 5-lipoxygenase by a 4-hydroxybenzofuran, L-656,224. Evidence for enzyme reduction and inhibitor degradation.

Authors:  C A Rouzer; D Riendeau; J P Falgueyret; C K Lau; M J Gresser
Journal:  Biochem Pharmacol       Date:  1991-05-01       Impact factor: 5.858

2.  Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.

Authors:  P J Manning; R M Watson; D J Margolskee; V C Williams; J I Schwartz; P M O'Byrne
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

Review 3.  Leukotriene B4 in inflammation.

Authors:  A W Ford-Hutchinson
Journal:  Crit Rev Immunol       Date:  1990       Impact factor: 2.214

4.  Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition.

Authors:  S Charleson; P Prasit; S Léger; J W Gillard; P J Vickers; J A Mancini; P Charleson; J Guay; A W Ford-Hutchinson; J F Evans
Journal:  Mol Pharmacol       Date:  1992-05       Impact factor: 4.436

5.  Leukotrienes: potent mediators of airway constriction.

Authors:  P J Piper
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

6.  Maximal airway narrowing to inhaled leukotriene D4 in normal subjects. Comparison and interaction with methacholine.

Authors:  E H Bel; H van der Veen; J A Kramps; J H Dijkman; P J Sterk
Journal:  Am Rev Respir Dis       Date:  1987-10

7.  L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.

Authors:  J Gillard; A W Ford-Hutchinson; C Chan; S Charleson; D Denis; A Foster; R Fortin; S Leger; C S McFarlane; H Morton
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

8.  Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4.

Authors:  D G Payan; A Missirian-Bastian; E J Goetzl
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Inhibition of endogenous leukotriene-mediated lung anaphylaxis in guinea pigs by a novel receptor antagonist ONO-1078.

Authors:  A Ishii; T Nakagawa; F Nambu; M Motoishi; T Miyamoto
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

10.  Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response.

Authors:  D W Goldman; E J Goetzl
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Leukotriene activity modulation in asthma.

Authors:  S L Spector
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 2.  Regulation of leukotriene biosynthesis.

Authors:  A W Ford-Hutchinson
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

Review 3.  Leukotrienes as a target in asthma therapy.

Authors:  N Chanarin; S L Johnston
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.